This inventor holds 36 USPTO granted patents and 8 published patent applications, primarily in X-Ray Technology. Top assignees: Xre Corporation, Other. Active years: 1979-2019.
Location History:
- West Concord, MA (US) (1979 - 1982)
- Lincoln, MA (US) (1982)
- Concord, MA (US) (1982)
- Litteton, MA (US) (1989)
- Littleton, MA (US) (1985 - 1998)
- Harvard, MA (US) (1983 - 2014)
- Ayer, MA (US) (2004 - 2019)
Company Filing History:
1 out of 2Â 
35 out of 834,411Â Years Active: 1979-2019
Areas of Expertise:
Title: Innovations in Radiotherapy: The Impact of John K Grady
Introduction
John K Grady, based in Harvard, MA, has made significant contributions to the field of radiotherapy, holding a remarkable total of 36 patents. His inventions focus on improving patient safety and treatment accuracy in radiation therapy, addressing critical concerns in oncology.
Latest Patents
Among his latest patented innovations is a mid-voltage radiotherapy system designed to minimize skin dose and reduce scatter around the treatment volume. This cutting-edge system features an X-ray tube operating between 100 to 800 kVp, which provides X-ray beams of 50 mm diameter or less, ideally around 30 mm. The system is configured to shift the entrance beam footprint on the body during treatment to predetermined positions. This ensures that the intervening tissue receives a safe dose rate, effectively limiting the skin area traversed during treatment to between 20 to 100 times the beam area.
Career Highlights
Grady's dedication to enhancing radiation therapy has led him to work with various companies, including XRE Corporation. His work has been crucial in developing advanced systems that address the complexities of radiation delivery in clinical settings.
Collaborations
Throughout his career, Grady has collaborated with distinguished colleagues, including Paul G Rice and Richard E Rice. These partnerships have fostered an environment of innovation and excellence in the development of radiotherapy technologies.
Conclusion
John K Grady's impressive portfolio of patents reflects his commitment to improving radiotherapy solutions. His innovative approaches not only enhance the accuracy of treatments but also prioritize patient safety, thereby making a lasting impact in the field of oncology.